Editorial: Can Glucagon Like Peptide 1 (GLP1) Agonists or Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors Ameliorate Non-Alcoholic Steatohepatitis in People with or without Diabetes?
| Title | Editorial: Can Glucagon Like Peptide 1 (GLP1) Agonists or Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors Ameliorate Non-Alcoholic Steatohepatitis in People with or without Diabetes? |
| Publication Type | Journal Article |
| Year of Publication | 2016 |
| Authors | Athyros, V. G., Katsiki N., & Karagiannis A. |
| Journal | Curr Vasc Pharmacol |
| Volume | 14 |
| Issue | 6 |
| Pagination | 494-497 |
| Date Published | 2016 |
| ISSN | 1875-6212 |
| Keywords | Diabetes Mellitus, Glucagon-Like Peptide 1, Humans, Hypoglycemic Agents, Liraglutide, Non-alcoholic Fatty Liver Disease, Sodium-Glucose Transporter 2 |
| Alternate Journal | Curr Vasc Pharmacol |
| PubMed ID | 27633289 |
